What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Enzyme
His primary scientific interests are in Internal medicine, Cardiology, Endocrinology, Pharmacology and Myocardial infarction.
His research on Internal medicine often connects related topics like Fatty acid.
His Cardiology research incorporates elements of Glycogen, Anaerobic exercise and Intracellular.
The various areas that Lionel H. Opie examines in his Endocrinology study include Trimetazidine, Activator, Phosphorylation and Cyclic adenosine monophosphate.
His research in Pharmacology intersects with topics in Adenosine, Reperfusion injury, Kinase, STAT protein and Ischemic preconditioning.
His study in Myocardial infarction is interdisciplinary in nature, drawing from both Volume overload, Muscle hypertrophy and Ventricle.
His most cited work include:
- 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. (3099 citations)
- Controversies in ventricular remodelling. (668 citations)
- Reperfusion injury and its pharmacologic modification. (470 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Cardiology, Endocrinology, Pharmacology and Ischemia.
His research investigates the connection with Internal medicine and areas like Anesthesia which intersect with concerns in Reperfusion injury.
His Cardiology research is multidisciplinary, incorporating perspectives in Verapamil and Nifedipine.
Endocrinology and Fatty acid are commonly linked in his work.
His studies examine the connections between Pharmacology and genetics, as well as such issues in Calcium channel, with regards to Diltiazem.
Lionel H. Opie works in the field of Myocardial infarction, namely Unstable angina.
He most often published in these fields:
- Internal medicine (64.80%)
- Cardiology (41.72%)
- Endocrinology (24.94%)
What were the highlights of his more recent work (between 2009-2020)?
- Internal medicine (64.80%)
- Cardiology (41.72%)
- Endocrinology (24.94%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cardiology, Endocrinology, Heart failure and Cardioprotection.
He has researched Internal medicine in several fields, including Diabetes mellitus, Placebo and Mitochondrion.
Lionel H. Opie does research in Cardiology, focusing on Coronary artery disease specifically.
His Heart failure research is multidisciplinary, incorporating elements of Adenosine triphosphate and Metabolism.
His studies in Cardioprotection integrate themes in fields like Melatonin, STAT3, Reperfusion injury and Pharmacology.
His Pharmacology research includes elements of Tumor necrosis factor alpha, Biochemistry and Beta.
Between 2009 and 2020, his most popular works were:
- 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. (3099 citations)
- Beta‐blockers for hypertension (311 citations)
- Out-of-Hospital Administration of Intravenous Glucose-Insulin-Potassium in Patients With Suspected Acute Coronary Syndromes: The IMMEDIATE Randomized Controlled Trial (178 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Enzyme
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Cardioprotection, Pharmacology and Cardiology.
His Placebo research extends to Internal medicine, which is thematically connected.
As part of the same scientific family, Lionel H. Opie usually focuses on Endocrinology, concentrating on Heart failure and intersecting with Carbohydrate metabolism, Beta oxidation and Triglyceride.
His studies deal with areas such as Tumor necrosis factor alpha, Biochemistry, Ischemia and Cardioprotective Agent as well as Pharmacology.
His work on Muscle hypertrophy as part of general Cardiology study is frequently connected to Concentric, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His research integrates issues of Coronary artery disease and Percutaneous coronary intervention in his study of Acute coronary syndrome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
